EPISODE · Nov 17, 2023 · 8 MIN
Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial
from Dr Alo Show · host Cardiologist & Personal Trainer Dr. Alo
Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics. https://dralo.net/links
NOW PLAYING
Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m